TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,976 | -99.2% | 197,884 | +197.8% | 0.04% | +600.0% |
Q3 2022 | $393,000 | +72.4% | 66,443 | +452.8% | 0.01% | +400.0% |
Q4 2021 | $228,000 | -68.7% | 12,020 | -45.1% | 0.00% | -66.7% |
Q3 2021 | $729,000 | +235.9% | 21,896 | +291.7% | 0.00% | +200.0% |
Q2 2021 | $217,000 | -79.2% | 5,590 | -74.1% | 0.00% | -80.0% |
Q1 2021 | $1,042,000 | +72.5% | 21,612 | +86.3% | 0.01% | +66.7% |
Q4 2020 | $604,000 | -57.0% | 11,603 | -77.9% | 0.00% | -66.7% |
Q3 2020 | $1,405,000 | +428.2% | 52,511 | +284.8% | 0.01% | +350.0% |
Q2 2020 | $266,000 | +60.2% | 13,645 | -19.0% | 0.00% | 0.0% |
Q1 2020 | $166,000 | +8.5% | 16,853 | -38.2% | 0.00% | +100.0% |
Q3 2019 | $153,000 | -42.7% | 27,266 | -11.6% | 0.00% | -50.0% |
Q2 2019 | $267,000 | +13.1% | 30,858 | +5.0% | 0.00% | 0.0% |
Q1 2019 | $236,000 | +50.3% | 29,377 | -23.3% | 0.00% | +100.0% |
Q4 2018 | $157,000 | +86.9% | 38,285 | +154.9% | 0.00% | 0.0% |
Q3 2018 | $84,000 | -22.9% | 15,022 | +117.6% | 0.00% | 0.0% |
Q4 2014 | $109,000 | – | 6,905 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |